{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:30:32Z","timestamp":1762252232738},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,7,2]],"date-time":"2015-07-02T00:00:00Z","timestamp":1435795200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s00415-015-7823-3","type":"journal-article","created":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T06:59:42Z","timestamp":1435733982000},"page":"2164-2170","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Efficacy and safety profile of prolonged release oxycodone in combination with naloxone (OXN PR) in Parkinson\u2019s disease patients with chronic pain"],"prefix":"10.1007","volume":"262","author":[{"given":"Graziella","family":"Madeo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommaso","family":"Schirinzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Natoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariangela","family":"Pierantozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Stefani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Dauri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Pisani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,2]]},"reference":[{"key":"7823_CR1","doi-asserted-by":"crossref","first-page":"E717","DOI":"10.1016\/j.parkreldis.2011.02.018","volume":"17","author":"KR Chaudhuri","year":"2011","unstructured":"Chaudhuri KR, Odin P, Antonini A, Martinez-Martin P (2011) Parkinson\u2019s disease: the non-motor issues. Parkinsonism Relat Disord 17:E717\u2013E723","journal-title":"Parkinsonism Relat Disord"},{"key":"7823_CR2","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nrneurol.2012.54","volume":"8","author":"G Wasner","year":"2012","unstructured":"Wasner G, Deuschl G (2012) Pains in Parkinson disease: many syndromes under one umbrella. Nat Rev Neurol 8:284\u2013941","journal-title":"Nat Rev Neurol"},{"issue":"485e","key":"7823_CR3","first-page":"91","volume":"27","author":"AD Ha","year":"2012","unstructured":"Ha AD, Jankovic J (2012) Pain in Parkinson\u2019s disease. Mov Disord 27(485e):91","journal-title":"Mov Disord"},{"key":"7823_CR4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.pain.2008.12.004","volume":"141","author":"AG Beiske","year":"2009","unstructured":"Beiske AG, Loge JH, Ronningen A, Svensson E (2009) Pain in Parkinson\u2019s disease: prevalence and characteristics. Pain 141:173\u2013177","journal-title":"Pain"},{"key":"7823_CR5","first-page":"2493","volume":"25","author":"DA Gallagher","year":"2010","unstructured":"Gallagher DA, Lees AJ, Schrag A (2010) What are the most important nonmotor symptoms in patients with Parkinson\u2019s disease and are we missing them? MovDisord 25:2493\u20132500","journal-title":"MovDisord"},{"key":"7823_CR6","first-page":"12","volume":"310","author":"P Martinez-Martin","year":"2011","unstructured":"Martinez-Martin P (2011) The importance of non-motor disturbances to quality of life in Parkinson\u2019s disease. J NeurolSci 310:12\u201316","journal-title":"J NeurolSci"},{"issue":"2","key":"7823_CR7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1517\/14728214.2012.677949","volume":"17","author":"S Perez-Lloret","year":"2012","unstructured":"Perez-Lloret S, Rey MV, Dellapina E, Pellaprat J, Brefel-Courbon C, Rascol O (2012) Emerging analgesic drugs for Parkinson\u2019s disease. Expert Opin Emerg Drugs 17(2):157\u2013171","journal-title":"Expert Opin Emerg Drugs"},{"issue":"7\u20138","key":"7823_CR8","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s007020050192","volume":"106","author":"D Berg","year":"1999","unstructured":"Berg D, Becker G, Reiners K (1999) Reduction of dyskinesia and induction of akinesia induced by morphine in two parkinsonian patients with severe sciatica. J Neural Transm 106(7\u20138):725\u2013728","journal-title":"J Neural Transm"},{"issue":"20","key":"7823_CR9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.12659\/MSMBR.890557","volume":"7","author":"C Snyder","year":"2014","unstructured":"Snyder C, Mantione K (2014) The effects of morphine on Parkinson\u2019s-related genes PINK1 and PARK2. Med Sci Monit Basic Res 7(20):63\u201369","journal-title":"Med Sci Monit Basic Res"},{"issue":"1","key":"7823_CR10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejpain.2008.06.012","volume":"13","author":"W Meissner","year":"2009","unstructured":"Meissner W, Leyendecker P, Mueller-Lissner S et al (2009) A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation. Eur J Pain 13(1):56\u201364","journal-title":"Eur J Pain"},{"key":"7823_CR11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiat 55:181\u2013184","journal-title":"J Neurol Neurosurg Psychiat"},{"issue":"1","key":"7823_CR12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(95)00156-5","volume":"65","author":"A Caraceni","year":"1996","unstructured":"Caraceni A, Mendoza TR, Mencaglia E et al (1996) A validation study of an Italian version of the Brief Pain Inventory (Breve Questionario per la Valutazione del Dolore). Pain 65(1):87\u201392","journal-title":"Pain"},{"issue":"7\u20138","key":"7823_CR13","first-page":"607","volume":"68","author":"C Bonezzi","year":"2002","unstructured":"Bonezzi C, Nava A, Barbieri M, Bettaglio R, Demartini L, Miotti D, Paulin L (2002) Validazione della versione italiana del Brief Pain Inventory nei pazienti con dolore cronico. Minerva Anestesiol 68(7\u20138):607\u2013611","journal-title":"Minerva Anestesiol"},{"issue":"2","key":"7823_CR14","first-page":"129","volume":"23","author":"CS Cleeland","year":"1994","unstructured":"Cleeland CS, Ryan KM (1994) Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singap 23(2):129\u2013138","journal-title":"Ann Acad Med Singap"},{"issue":"4","key":"7823_CR15","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3111\/13696990903430481","volume":"12","author":"AM Rentz","year":"2009","unstructured":"Rentz AM, Yu R, M\u00fcller-Lissner S, Leyendecker P (2009) Validation of the Bowel Function Index to detect clinically meaningful changes in opioid-induced constipation. J Med Econ 12(4):371\u2013383","journal-title":"J Med Econ"},{"key":"7823_CR16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.parkreldis.2003.12.001","volume":"10","author":"BH Quittenbaum","year":"2004","unstructured":"Quittenbaum BH, Grahn B (2004) Quality of life and pain in Parkinson\u2019s disease: a controlled cross-sectional study. Parkinsonism Relat Disord 10:129\u2013136","journal-title":"Parkinsonism Relat Disord"},{"key":"7823_CR17","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1600-0404.2008.01114.x","volume":"119","author":"JH Roh","year":"2009","unstructured":"Roh JH, Kim BJ, Jang JH, Seo WK, Lee SH, Kim JH, Oh K, Park KW, Lee DH, Koh SB (2009) The relationship of pain and health-related quality of life in Korean patients with Parkinson\u2019s disease. Acta Neurol Scand 119:397\u2013403","journal-title":"Acta Neurol Scand"},{"key":"7823_CR18","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/mds.23135","volume":"25","author":"M Politis","year":"2010","unstructured":"Politis M, Wu K, Molloy S, Bain G, Chaudhuri P, Piccini KR (2010) Parkinson\u2019s disease symptoms: the patient\u2019s perspective. Mov Disord 25:1646\u20131651","journal-title":"Mov Disord"},{"key":"7823_CR19","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0002-9610(01)00782-6","volume":"182","author":"M Pappagallo","year":"2008","unstructured":"Pappagallo M (2008) Incidence, prevalence, and management of opioid bowel dysfunction. Am J Surg 182:S11\u2013S18","journal-title":"Am J Surg"},{"key":"7823_CR20","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1185\/03007990802584454","volume":"24","author":"K Simpson","year":"2008","unstructured":"Simpson K, Leyendecker P, Hopp M et al (2008) Fixed-ratio combination oxycodone\/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer pain. Curr Med Res Opin 24:3503\u20133512","journal-title":"Curr Med Res Opin"},{"key":"7823_CR21","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1517\/14656560902796798","volume":"10","author":"O L\u00f6wenstein","year":"2009","unstructured":"L\u00f6wenstein O, Leyendecker P, Hopp M et al (2009) Combined prolonged-release oxycodone and naloxone improves bowel function in patients receiving opioids for moderate-to-severe non-malignant chronic pain: a randomised controlled trial. Expert Opin Pharmacother 10:531\u2013543","journal-title":"Expert Opin Pharmacother"},{"key":"7823_CR22","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1742-1241.2010.02360.x","volume":"64","author":"A Sandner-Kiesling","year":"2010","unstructured":"Sandner-Kiesling A, Leyendecker P, Hopp M et al (2010) Long-term efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of non-cancer chronic pain. Int J Clin Pract 64:763\u2013774","journal-title":"Int J Clin Pract"},{"key":"7823_CR23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1472-6904-10-12","volume":"10","author":"O L\u00f6wenstein","year":"2010","unstructured":"L\u00f6wenstein O, Leyendecker P, Lux EA et al (2010) Efficacy and safety of combined prolongedrelease oxycodone and naloxone in the management of moderate\/severe chronic nonmalignant pain: results of a prospectively designed pooled analysis of two randomised, double-blind clinical trials. BMC Clin Pharmacol 10:12","journal-title":"BMC Clin Pharmacol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-015-7823-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-015-7823-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-015-7823-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T19:56:17Z","timestamp":1717962977000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-015-7823-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,2]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["7823"],"URL":"https:\/\/doi.org\/10.1007\/s00415-015-7823-3","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,2]]}}}